Science. The Center of Everything We Do.
The diversity and complexity of therapeutic modalities, such as cell and gene therapies and RNA, is increasing. Scientists require innovative, purpose-built software to facilitate day-to-day laboratory work and to interpret complex biological data so they can identify the best drug candidates, the optimal high-titer production cell lines, the most economical process conditions, or the responders and non-responders in a patient population.
This is where Genedata comes in.
We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types.
Hisham Hamadeh, Ph.D.
Vice President, Global Head of Data Sciences
We especially appreciated the high level of expertise and support provided by Genedata, which enabled us to optimize every stage of our analytical processes—while incorporating industry best practices—and quickly generate high-quality results.
Juliet Padden Ph.D.
Laboratory Head Analytical Development
During our initial deployment, we recorded quantifiable increases in productivity. The number of results posted to our data warehouse more than doubled, indicating that we could capture results from many more experiments, while the cost of running day-to-day operations decreased.
Vice President, Discovery Biology, Discovery Sciences
The Biologics Data Platform supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process.
Heiner Apeler, Ph.D.
Director of Molecular and Antibody Biology
The Genedata platform is an important cornerstone in enhancing the analytical capabilities of our teams with cutting-edge digital technology.
Joern Peter Halle
Head of Immuno-oncology and External Innovation
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
Sergio Rotstein, Ph.D.
Director of Research Business Technology
Genedata enables us to integrate a wide variety of complex data generated by novel experimental workflows so we can gain a holistic molecular understanding of production cells with the goal of developing high performing bioproduction processes.
Ruth Wagner, Ph.D.
Group Manager of Cell Line Engineering
We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. We chose Genedata because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines.
Department Manager of Clinical Pharmacology
We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata addresses many of our requirements off-the-shelf, eliminating the need for expensive customization.
Hugo de Wit
Genedata gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow.
Dominik Maurer, Ph.D.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in next-generation biotechnology innovations. Genedata was our obvious choice.
Harald Bradl, Ph.D.
Director, Cell Culture and Process Sciences
Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process – right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments.
Thomas Sandal, Ph.D.
Vice President, R&D
Genedata tracks all biologics molecules from early discovery to development, and gives the UCB R&D organization central access to all relevant information on these molecules.
Senior Director of R&D Informatics
Seamless. All Data in One Place.
Genedata provides a fully integrated digital platform connecting all groups and functions in biopharma R&D organizations across research to development to translational and clinical research. All data is tracked along the overall R&D workflow, integrating molecules, cells, samples, processes, and patients – from start to finish in one unified system. This simplifies data entry, data processing, and analysis, regardless of whether it's for bispecific antibody engineering, NGS-based cell line development, or patient stratification for cell therapies.
Simplifying Daily Work. Every Day.
Struggling with data handling, reporting, double-data entry, or just getting the data from your lab instruments into a report? Effective data management is more essential than ever for the future delivery of innovative biopharmaceutical drugs. Novel multi-specific antibodies, cell and gene therapies, RNA vaccines, immuno-oncology drugs – the Genedata platform can model any process and provides ready-to-use functionalities that meet real-world R&D requirements. Easy-to-use step-by-step wizards enable even first-time users to quickly get up and running. Built-in tools facilitate data interpretation and provide detailed analysis reports at the click of a button.
R&D Evolves Fast. Flexibility is Key.
The Genedata platform delivers the best of both worlds – out-the-box functionality of an off-the-shelf solution and the full flexibility of custom software to meet the rapid advances in biopharma R&D. New molecule formats, new processes, new instruments – no need to ask a software engineer. Users can quickly integrate new functionality into the overall workflow using Genedata’s unique codeless configuration technology. By reducing process complexity and automating data operations, scientists have more time for the work that really matters – discovering and developing breakthrough therapies faster to improve outcomes sooner for patients worldwide.
Our Customer Stories
Informed Decision-Making Along the R&D Process
“Our teams constantly bring in new science and innovative technologies that require custom workflows, additional metadata, or integration with robotics and automation equipment. By having the Genedata enterprise platform as our central data backbone, we can build our own in-house solutions around it and keep all the information secure, stable, and accessible in one central place.”
Higher-Quality, More Reliable Data
“The easy integration of high-quality, information-rich MS data from Genedata Expressionist into our existing Genedata Screener data analysis platform means that we can take full advantage of the increase in speed and data quality that AMI-MS provides.”
Faster Development of Bispecific Antibodies
Genedata helps Amgen to enhance the developability of bispecific antibodies enabling high-quality, automated analysis of complex biophysical data from large candidate panels. It also allows straightforward sharing of results with other teams, helping accelerate development and adoption of new approaches.
Better Use of Clinical and Translational Data
“The Genedata platform is an important cornerstone in enhancing the analytical capabilities of our teams with cutting-edge digital technology. ... a digital biomarker research platform that will enable Merck scientists to better utilize clinical and translational data to generate innovative ideas for new biomarkers and drug targets.”